It is the first medication in a class known as dual-agonists
glucagon suppression, lowering hepatic glucose output Central Nervous System: Decreases food intake by targeting homeostatic and hedonic appetite pathways (hindbrain/hypothalamus), reducing hunger and cravings, and enhancing satiety Gastrointestinal Tract: Delays gastric emptying, contributing to satiety (transient effect at higher doses) Adiposity/Energy Intake : Weight loss is primarily driven by sustained reduction in caloric intake, not increased energy expenditure Biological Activity Potent GLP-1 receptor agonist Enhances insulin secretion (glucose-dependent) Suppresses glucagon secretion Reduces appetite and caloric intake Produces significant, sustained body weight loss Improves cardiometabolic risk factors (glycemia, blood pressure, lipids) Storage Refrigerate once reconstituted
This certification ensures that what is on the label is in the bag, and nothing else
A treatment for pre-diabetes
Deductibles, copays, and coinsurance vary by plan
Frequently Asked Questions BPC-157, short for Body Protection Compound-157, is a synthetic peptide known for promoting tissue repair, reducing inflammation, and supporting immune balance
